Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Nephros (NEPH) Shares Outstanding (Diluted Average) (2016 - 2025)

Historic Shares Outstanding (Diluted Average) for Nephros (NEPH) over the last 8 years, with Q3 2025 value amounting to $11.0 million.

  • Nephros' Shares Outstanding (Diluted Average) rose 434.76% to $11.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.0 million, marking a year-over-year increase of 434.76%. This contributed to the annual value of $10.6 million for FY2024, which is 207.96% up from last year.
  • According to the latest figures from Q3 2025, Nephros' Shares Outstanding (Diluted Average) is $11.0 million, which was up 434.76% from $10.8 million recorded in Q2 2025.
  • Nephros' 5-year Shares Outstanding (Diluted Average) high stood at $11.0 million for Q3 2025, and its period low was $10.3 million during Q4 2022.
  • In the last 4 years, Nephros' Shares Outstanding (Diluted Average) had a median value of $10.5 million in 2023 and averaged $10.5 million.
  • In the last 5 years, Nephros' Shares Outstanding (Diluted Average) dropped by 1.67% in 2023 and then surged by 434.76% in 2025.
  • Over the past 4 years, Nephros' Shares Outstanding (Diluted Average) (Quarter) stood at $10.3 million in 2022, then grew by 0.86% to $10.4 million in 2023, then grew by 2.08% to $10.6 million in 2024, then rose by 4.14% to $11.0 million in 2025.
  • Its last three reported values are $11.0 million in Q3 2025, $10.8 million for Q2 2025, and $10.6 million during Q1 2025.